Related Experiment Video
Updated: Jul 13, 2026

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
Structural basis for glutamate racemase inhibition
Kook-Han Kim1, Young-Jong Bong, Joon Kyu Park
1Life Sciences Division, Korea Institute of Science and Technology, 39-1 Hawolkok-Dong, Sungbuk-Gu, Seoul, Korea.
Structural insights into glutamate racemase (GluR) from Streptococcus pyogenes reveal its potential as a novel antibacterial drug target. Understanding inhibitor binding provides a basis for designing new antibiotics against bacterial infections.
Area of Science:
- Biochemistry
- Structural Biology
- Microbiology
Background:
- D-Glutamic acid is essential for bacterial peptidoglycan synthesis.
- Glutamate racemase (GluR) inter-converts D and L-glutamate, making it a key enzyme in this pathway.
- GluR is a promising target for developing new antibacterial agents.
Purpose of the Study:
- To determine the crystal structures of Streptococcus pyogenes GluR.
- To investigate the structural basis of inhibitor binding to GluR.
- To provide insights for the rational design of GluR inhibitors.
Main Methods:
- X-ray crystallography was used to obtain structures of GluR in inhibitor-free and inhibitor-bound forms.
- Crystallization yielded diffraction data to resolutions of 2.25 A and 2.5 A.
- Biophysical methods like gel filtration and dynamic light scattering were employed.
Main Results:
- The crystal structures revealed GluR comprises two pseudo-2-fold symmetric alpha/beta domains with the active site at the interface.
- A potent competitive inhibitor, gamma-2-naphthylmethyl-D-glutamate, binds via hydrogen bonds and hydrophobic interactions.
- Inhibitor binding induced conformational changes in an active site loop.
- GluR exists as a dimer in both crystal forms, with conserved dimer interface interactions.
Conclusions:
- The determined structures provide a detailed molecular understanding of GluR.
- The findings highlight GluR as a viable target for antibacterial drug development.
- Structural information can guide the design of more effective GluR-targeting antibiotics.
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Racemic Mixtures and the Resolution of Enantiomers
